Replication-selective microbiological agents: fighting cancer with targeted germ warfare

被引：47
|
作者：
Kirn, DH [1 ]
机构：
[1] Hammersmith Hosp, Imperial Coll Sch Med, Program Viral & Genet Therapy Canc, Imperial Canc Res Fund,Mol Oncol Unit, London W12 0NN, England
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 105卷 / 07期
关键词：
D O I：
10.1172/JCI9761
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：837 / 839
页数：3
相关论文
共 46 条
  • [41] Selective Visualization of Cyclooxygenase-2 in Inflammation and Cancer by Targeted Fluorescent Imaging Agents
    Uddin, Md. Jashim
    Crews, Brenda C.
    Blobaum, Anna L.
    Kingsley, Philip J.
    Gorden, D. Lee
    McIntyre, J. Oliver
    Matrisian, Lynn M.
    Subbaramaiah, Kotha
    Dannenberg, Andrew J.
    Piston, David W.
    Marnett, Lawrence J.
    CANCER RESEARCH, 2010, 70 (09) : 3618 - 3627
  • [42] Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients
    J Nemunaitis
    C Cunningham
    A W Tong
    L Post
    G Netto
    A S Paulson
    D Rich
    A Blackburn
    B Sands
    B Gibson
    B Randlev
    S Freeman
    Cancer Gene Therapy, 2003, 10 : 341 - 352
  • [43] Low-dose irradiation potentiates the oncolytic effect of replication-selective herpes simplex virus-1 mutant-based therapy for cervical cancer
    Blank, SV
    Rubin, SC
    Coukos, G
    Molnar-Kimber, KL
    Albelda, SM
    CANCER GENE THERAPY, 1999, 6 (06) : S15 - S16
  • [44] Novel mitochondria-targeted and fluorescent DNA alkylation agents with highly selective activity against cancer cells
    Chen, Xiuli
    Peng, Wentao
    Huang, Shenzhen
    Yang, Chao
    Hu, Mingxing
    Yang, Shuping
    Yang, Shengyong
    Xie, Yongmei
    Chen, Hao
    Lei, Ning
    Luo, Yi
    Li, Kun
    DYES AND PIGMENTS, 2019, 170
  • [45] Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
    Watanabe, T
    Hioki, M
    Fujiwara, T
    Nishizaki, M
    Kagawa, S
    Taki, M
    Kishimoto, H
    Endo, Y
    Urata, Y
    Tanaka, N
    Fujiwara, T
    EXPERIMENTAL CELL RESEARCH, 2006, 312 (03) : 256 - 265
  • [46] Efficacy of enobosarm, a selective androgen receptor (AR) targeting agent, in patients with metastatic AR plus /ER plus breast cancer resistant to estrogen receptor targeted agents and CDK 4/6 inhibitor in a phase II clinical study
    Palmieri, C.
    Linden, H.
    Birrell, S.
    Lim, E.
    Schwartzberg, L. S.
    Rugo, H. S.
    Cobb, P.
    Jain, K.
    Vogel, C.
    O'Shaughnessy, J.
    Johnston, S. R. D.
    Getzenberg, R. H.
    Barnette, K. G.
    Steiner, M.
    Brufsky, A. M.
    Overmoyer, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S66 - S66
12345